HomeHealthcare & Life SciencesBiotechnology Stargardts Treatment Market

Middle East And Africa Stargardts Treatment Market Size & Outlook, 2026-2034


Middle East And Africa Stargardts Treatment Market Insights

  • Based on Reed Intelligence findings, the Middle East And Africa Stargardts Treatment Market size reached USD 354.42 Million in 2025 and is expected to grow to USD 917.68 Million by 2034.
  • During 2026–2034, the market is forecasted to advance at a CAGR of 11.28%.
  • Gene Therapy represented the largest share of the Treatment Type market in terms of size in 2025.
  • Among the Treatment Type segments, Nutritional and Supportive Therapy is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

Other Key Findings


  • Middle East And Africa held 8.95% share of the global Stargardts Treatment Market size in 2025.
  • United States is expected to remain the largest contributor to the global market size by 2034.
  • By 2034, United Arab Emirates is anticipated to record the highest growth in Middle East and Africa, with the market size expected to reach USD 495.91 Million.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 354.42 Million
Market Size In 2034 USD 917.68 Million
Largest segment Gene Therapy
Units Revenue in USD Million
CAGR 11.28% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Treatment Type
  1. Gene Therapy
  2. Stem Cell Therapy
  3. Pharmacological Therapy
  4. Nutritional and Supportive Therapy
Disease Stage
  1. Early Stage
  2. Intermediate Stage
  3. Advanced Stage
End-Use
  1. Hospitals and Ophthalmology Clinics
  2. Research Institutes
  3. Specialty Eye Centers
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports